MaxCyte CFO to step down in first half of 2026

* MaxCyte (MXCT [https://seekingalpha.com/symbol/MXCT]) announced [https://seekingalpha.com/pr/20305110-maxcyte-announces-planned-cfo-transition-in-2026] that chief financial officer Douglas Swirsky will transition from his role in the first half of 2026.
* Swirsky will remain CFO until a successor is appointed to ensure a smooth and orderly transition.
* After the transition, Swirsky will serve in an advisory capacity to support strategic initiatives and continuity.

MORE ON MAXCYTE

* MaxCyte announces 34% workforce reduction to cut costs [https://seekingalpha.com/news/4497465-maxcyte-announces-34-workforce-reduction-to-cut-costs]
* Seeking Alpha’s Quant Rating on MaxCyte [https://seekingalpha.com/symbol/MXCT/ratings/quant-ratings]
* Historical earnings data for MaxCyte [https://seekingalpha.com/symbol/MXCT/earnings]
* Financial information for MaxCyte [https://seekingalpha.com/symbol/MXCT/income-statement]